209 related articles for article (PubMed ID: 20504876)
1. Defective p53 antiangiogenic signaling in glioblastoma.
Berger B; Capper D; Lemke D; Pfenning PN; Platten M; Weller M; von Deimling A; Wick W; Weiler M
Neuro Oncol; 2010 Sep; 12(9):894-907. PubMed ID: 20504876
[TBL] [Abstract][Full Text] [Related]
2. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
[TBL] [Abstract][Full Text] [Related]
3. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.
Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G
Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569
[TBL] [Abstract][Full Text] [Related]
4. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.
Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G
Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells.
Yao Y; Kubota T; Sato K; Takeuchi H; Handa Y; Matsukawa S
J Neurooncol; 2006 Feb; 76(3):219-25. PubMed ID: 16283438
[TBL] [Abstract][Full Text] [Related]
6. Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression.
Kaur B; Brat DJ; Calkins CC; Van Meir EG
Am J Pathol; 2003 Jan; 162(1):19-27. PubMed ID: 12507886
[TBL] [Abstract][Full Text] [Related]
7. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
[TBL] [Abstract][Full Text] [Related]
8. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis.
Nishimori H; Shiratsuchi T; Urano T; Kimura Y; Kiyono K; Tatsumi K; Yoshida S; Ono M; Kuwano M; Nakamura Y; Tokino T
Oncogene; 1997 Oct; 15(18):2145-50. PubMed ID: 9393972
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adenovirus expressing wild-type p53 is antiangiogenic: a proposed mechanism for bystander effect.
Nishizaki M; Fujiwara T; Tanida T; Hizuta A; Nishimori H; Tokino T; Nakamura Y; Bouvet M; Roth JA; Tanaka N
Clin Cancer Res; 1999 May; 5(5):1015-23. PubMed ID: 10353734
[TBL] [Abstract][Full Text] [Related]
10. Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.
Kazantseva M; Eiholzer RA; Mehta S; Taha A; Bowie S; Roth I; Zhou J; Joruiz SM; Royds JA; Hung NA; Slatter TL; Braithwaite AW
J Pathol; 2018 Sep; 246(1):77-88. PubMed ID: 29888503
[TBL] [Abstract][Full Text] [Related]
11. Introduction of wild-type p53 enhances thrombospondin-1 expression in human glioma cells.
Harada H; Nakagawa K; Saito M; Kohno S; Nagato S; Furukawa K; Kumon Y; Hamada K; Ohnishi T
Cancer Lett; 2003 Feb; 191(1):109-19. PubMed ID: 12609716
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
Hsu SC; Volpert OV; Steck PA; Mikkelsen T; Polverini PJ; Rao S; Chou P; Bouck NP
Cancer Res; 1996 Dec; 56(24):5684-91. PubMed ID: 8971176
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability.
Miyamoto N; Yamamoto H; Taniguchi H; Miyamoto C; Oki M; Adachi Y; Imai K; Shinomura Y
Cancer Lett; 2007 Aug; 254(1):42-53. PubMed ID: 17374440
[TBL] [Abstract][Full Text] [Related]
15. TP53 mutated glioblastoma stem-like cell cultures are sensitive to dual mTORC1/2 inhibition while resistance in TP53 wild type cultures can be overcome by combined inhibition of mTORC1/2 and Bcl-2.
Venkatesan S; Hoogstraat M; Caljouw E; Pierson T; Spoor JK; Zeneyedpour L; Dubbink HJ; Dekker LJ; van der Kaaij M; Kloezeman J; Berghauser Pont LM; Besselink NJ; Luider TM; Joore J; Martens JW; Lamfers ML; Sleijfer S; Leenstra S
Oncotarget; 2016 Sep; 7(36):58435-58444. PubMed ID: 27533080
[TBL] [Abstract][Full Text] [Related]
16. HDMX regulates p53 activity and confers chemoresistance to 3-bis(2-chloroethyl)-1-nitrosourea.
Jin G; Cook S; Cui B; Chen WC; Keir ST; Killela P; Di C; Payne CA; Gregory SG; McLendon R; Bigner DD; Yan H
Neuro Oncol; 2010 Sep; 12(9):956-66. PubMed ID: 20472715
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53.
Clark AJ; Chan DC; Chen MY; Fillmore H; Dos Santos WG; Van Meter TE; Graf MR; Broaddus WC
J Neurooncol; 2007 Jun; 83(2):163-72. PubMed ID: 17206472
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Bacher M; Schrader J; Thompson N; Kuschela K; Gemsa D; Waeber G; Schlegel J
Am J Pathol; 2003 Jan; 162(1):11-7. PubMed ID: 12507885
[TBL] [Abstract][Full Text] [Related]
19. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
[TBL] [Abstract][Full Text] [Related]
20. P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.
Zerrouqi A; Pyrzynska B; Febbraio M; Brat DJ; Van Meir EG
J Clin Invest; 2012 Apr; 122(4):1283-95. PubMed ID: 22378045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
